{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:18:05Z","timestamp":1769843885258,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of KwaZulu-Natal College of Health Sciences Doctoral Research Scholarship grant"},{"name":"Health and Welfare Sector Education and Training Authority"},{"name":"MTN-Swaziland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4540-1","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T06:43:02Z","timestamp":1528353782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-8308","authenticated-orcid":false,"given":"Themba G.","family":"Ginindza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benn","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"issue":"12","key":"4540_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"key":"4540_CR2","unstructured":"Word Health Organisation., Institut Catala\u2019 d\u2019Oncologia (ICO). Human Papillomavirus and related cancers, HPV information centre. Gevena: WHO\/ICO; 2010."},{"key":"4540_CR3","first-page":"1","volume":"91","author":"IARC","year":"2007","unstructured":"IARC. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monogr Eval Carcinog Risks Hum. 2007;91:1\u2013528.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"4540_CR4","volume-title":"UNHigh-level Meeting on Non-communicable Diseases","author":"WHO","year":"2011","unstructured":"WHO. UNHigh-level Meeting on Non-communicable Diseases. New York: General Assembly, United Nations; 2011."},{"issue":"12","key":"4540_CR5","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893\u2013917.","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"4540_CR6","first-page":"S3\/42","volume":"24","author":"AB Moscicki","year":"2006","unstructured":"Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24(Suppl 3):S3\/42\u201351.","journal-title":"Vaccine"},{"issue":"8","key":"4540_CR7","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/ijc.27835","volume":"132","author":"M Sharma","year":"2013","unstructured":"Sharma M, Bruni L, Diaz M, Castellsague X, de Sanjose S, Bosch FX, Kim JJ. Using HPV prevalence to predict cervical cancer incidence. Int J Cancer. 2013;132(8):1895\u2013900.","journal-title":"Int J Cancer"},{"issue":"11","key":"4540_CR8","first-page":"659","volume":"10","author":"N Jay","year":"2000","unstructured":"Jay N, Moscicki AB. Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read. 2000;10(11):659\u201368.","journal-title":"AIDS Read"},{"key":"4540_CR9","unstructured":"WHO, Cancer Registration: Principles and Methods. Lyon: IARC; 1991. \n                    https:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/epi\/sp95\/SP95.pdf\n                    \n                  ."},{"key":"4540_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/1742-6413.54916","volume":"6","author":"S Okonda","year":"2009","unstructured":"Okonda S, Wright C, Michelow P. The status of cervical cytology in Swaziland, southern Africa: a descriptive study. Cytojournal. 2009;6:14.","journal-title":"Cytojournal"},{"key":"4540_CR11","unstructured":"The Kingdom of Swaziland, Ministry of Health: Cervical Cancer Screening Guidelines. Mbabane: Sexual Reproductive Health Unit; 2013."},{"key":"4540_CR12","volume-title":"GLOBOCAN 2012: Estimated cancer Incidence, Mortality and Prevalence Worldwide 2012","author":"JSI Ferlay","year":"2012","unstructured":"Ferlay JSI, Ervik M, et al. GLOBOCAN 2012: Estimated cancer Incidence, Mortality and Prevalence Worldwide 2012. Lyon, France: IARC; 2012."},{"key":"4540_CR13","unstructured":"The Kingdom of Swaziland Gorvernment and UNFPA: SWAZILAND POPULATION PROJECTIONS 2007-2030. In. Edited by Office CS; 2007."},{"issue":"3","key":"4540_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.canep.2015.04.006","volume":"39","author":"K Sartorius","year":"2015","unstructured":"Sartorius K, Sartorius B, Aldous C, Govender P, Madiba T. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiol. 2015;39(3):284\u201390.","journal-title":"Cancer Epidemiol"},{"key":"4540_CR15","volume-title":"Human Papillomavirus and Related diseases report","author":"Information Centre on HPV and Cancer (ICO)","year":"2016","unstructured":"Information Centre on HPV and Cancer (ICO). Human Papillomavirus and Related diseases report. Spain: Institut Catal\u00e0 d\u2019Oncologia; 2016."},{"issue":"1","key":"4540_CR16","doi-asserted-by":"publisher","first-page":"e0170189","DOI":"10.1371\/journal.pone.0170189","volume":"12","author":"TG Ginindza","year":"2017","unstructured":"Ginindza TG, Dlamini X, Almonte M, Herrero R, Jolly PE, Tsoka-Gwegweni JM, Weiderpass E, Broutet N, Sartorius B. Prevalence of and associated risk factors for high risk human papillomavirus among sexually active women, Swaziland. PLoS One. 2017;12(1):e0170189.","journal-title":"PLoS One"},{"issue":"Suppl 5","key":"4540_CR17","doi-asserted-by":"publisher","first-page":"F16","DOI":"10.1016\/j.vaccine.2008.02.040","volume":"26","author":"D Debicki","year":"2008","unstructured":"Debicki D, Ferko N, Demarteau N, Gallivan S, Bauch C, Anonychuk A, Mantovani L, Capri S, Chou CY, Standaert B, et al. Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination. Vaccine. 2008;26(Suppl 5):F16\u201328.","journal-title":"Vaccine"},{"issue":"12","key":"4540_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","volume":"151","author":"ER Myers","year":"2000","unstructured":"Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000;151(12):1158\u201371.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"4540_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/aje\/kwu159","volume":"180","author":"NG Campos","year":"2014","unstructured":"Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol. 2014;180(5):545\u201355.","journal-title":"Am J Epidemiol"},{"key":"4540_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1478-7547-6-4","volume":"6","author":"SL Kulasingam","year":"2008","unstructured":"Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER. Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis. Cost effectiveness and resource allocation : C\/E. 2008;6:4.","journal-title":"Cost effectiveness and resource allocation : C\/E"},{"key":"4540_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2407-14-365","volume":"14","author":"N Demarteau","year":"2014","unstructured":"Demarteau N, Morhason-Bello IO, Akinwunmi B, Adewole IF. Modeling optimal cervical cancer prevention strategies in Nigeria. BMC Cancer. 2014;14:365.","journal-title":"BMC Cancer"},{"issue":"17","key":"4540_CR22","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/jnci\/djg037","volume":"95","author":"NF Schlecht","year":"2003","unstructured":"Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 2003;95(17):1336\u201343.","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"4540_CR23","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"4540_CR24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","volume":"116","author":"AB Moscicki","year":"2010","unstructured":"Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol. 2010;116(6):1373\u201380.","journal-title":"Obstet Gynecol"},{"key":"4540_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-9378-2-15","volume":"2","author":"RP Insinga","year":"2007","unstructured":"Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E. Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infectious agents and cancer. 2007;2:15.","journal-title":"Infectious agents and cancer"},{"key":"4540_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2334-9-119","volume":"9","author":"RP Insinga","year":"2009","unstructured":"Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis. 2009;9:119.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4540_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00145037","volume":"5","author":"V Kataja","year":"1989","unstructured":"Kataja V, Syrjanen K, Mantyjarvi R, Vayrynen M, Syrjanen S, Saarikoski S, Parkkinen S, Yliskoski M, Salonen JT, Castren O. Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol. 1989;5(1):1\u20137.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"4540_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","volume":"91","author":"P Holowaty","year":"1999","unstructured":"Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999;91(3):252\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4540_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.canlet.2005.02.023","volume":"231","author":"K Matsumoto","year":"2006","unstructured":"Matsumoto K, Yasugi T, Oki A, Fujii T, Nagata C, Sekiya S, Hoshiai H, Taketani Y, Kanda T, Kawana T, et al. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia. Cancer Lett. 2006;231(2):309\u201313.","journal-title":"Cancer Lett"},{"issue":"3","key":"4540_CR30","first-page":"210","volume":"50","author":"R Wang","year":"2015","unstructured":"Wang R, Li X, Qian M, Niu J, You Z. The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I. Zhonghua fu chan ke za zhi. 2015;50(3):210\u20135.","journal-title":"Zhonghua fu chan ke za zhi"},{"issue":"4 Pt 2","key":"4540_CR31","first-page":"727","volume":"92","author":"J Melnikow","year":"1998","unstructured":"Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;92(4 Pt 2):727\u201335.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4540_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317.","journal-title":"Clin Microbiol Rev"},{"key":"4540_CR33","first-page":"328909","volume":"2013","author":"MG Loffredo D'Ottaviano","year":"2013","unstructured":"Loffredo D'Ottaviano MG, Discacciati MG, Andreoli MA, Costa MC, Termini L, Rabelo-Santos SH, Villa LL, Zeferino LC. HPV 16 is related to the progression of cervical intraepithelial neoplasia grade 2: a case series. Obstet Gynecol Int. 2013;2013:328909.","journal-title":"Obstet Gynecol Int"},{"issue":"2","key":"4540_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1309\/0UP5PJK9RYF7BPHM","volume":"128","author":"M Omori","year":"2007","unstructured":"Omori M, Hashi A, Nakazawa K, Yuminamochi T, Yamane T, Hirata S, Katoh R, Hoshi K. Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types. Am J Clin Pathol. 2007;128(2):208\u201317.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"4540_CR35","first-page":"2319","volume":"30","author":"AC Guedes","year":"2010","unstructured":"Guedes AC, Zeferino LC, Syrjanen KJ, Brenna SM. Short-term outcome of cervical intraepithelial neoplasia grade 2: considerations for management strategies and reproducibility of diagnosis. Anticancer Res. 2010;30(6):2319\u201323.","journal-title":"Anticancer Res"},{"issue":"3","key":"4540_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/IGC.0b013e3181d15a11","volume":"20","author":"Y Matsumoto","year":"2010","unstructured":"Matsumoto Y, Mabuchi S, Muraji M, Morii E, Kimura T. Squamous cell carcinoma of the uterine cervix producing granulocyte colony-stimulating factor: a report of 4 cases and a review of the literature. Int J Gynecol Cancer. 2010;20(3):417\u201321.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"4540_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MR McCredie","year":"2008","unstructured":"McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. The Lancet Oncology. 2008;9(5):425\u201334.","journal-title":"The Lancet Oncology"},{"key":"4540_CR38","volume-title":"SEER Cancer statistics review, 1975-2013. SEER stat fact sheets: cervix uteri Cancer","author":"NNA Howlader","year":"2015","unstructured":"Howlader NNA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer statistics review, 1975-2013. SEER stat fact sheets: cervix uteri Cancer. Bethesda, MD: National Cancer Institute; 2015."},{"issue":"9","key":"4540_CR39","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.bjc.6603653","volume":"96","author":"NW Bulkmans","year":"2007","unstructured":"Bulkmans NW, Berkhof J, Bulk S, Bleeker MC, van Kemenade FJ, Rozendaal L, Snijders PJ, Meijer CJ. High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer. 2007;96(9):1419\u201324.","journal-title":"Br J Cancer"},{"issue":"2","key":"4540_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG Ostor","year":"1993","unstructured":"Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186\u201392.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"4540_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","volume":"113","author":"PE Castle","year":"2009","unstructured":"Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113(1):18\u201325.","journal-title":"Obstet Gynecol"},{"key":"4540_CR42","doi-asserted-by":"crossref","unstructured":"Meyskens FL, Jr., Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, Johnson CS, Alberts DS: Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994, 86(7):539\u2013543.","DOI":"10.1093\/jnci\/86.7.539"},{"key":"4540_CR43","unstructured":"Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F: GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11 [internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: \n                    http:\/\/globocan.iarc.fr\n                    \n                  , accessed on 10\/05\/2016. In.; 2013."},{"key":"4540_CR44","volume-title":"Globocan: Cervical cancer and mortality world-wide in 2008","author":"IARC","year":"2008","unstructured":"IARC: Globocan: Cervical cancer and mortality world-wide in 2008.; 2008."},{"key":"4540_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2015.02.018","volume":"34","author":"S Gul","year":"2015","unstructured":"Gul S, Murad S, Javed A. Prevalence of high risk human papillomavirus in cervical dysplasia and cancer samples from twin cities in Pakistan. Int J Infect Dis. 2015;34:14\u20139.","journal-title":"Int J Infect Dis"},{"issue":"18","key":"4540_CR46","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/jnci\/djr283","volume":"103","author":"HC Chen","year":"2011","unstructured":"Chen HC, Schiffman M, Lin CY, Pan MH, You SL, Chuang LC, Hsieh CY, Liaw KL, Hsing AW, Chen CJ. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst. 2011;103(18):1387\u201396.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"4540_CR47","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djq356","volume":"102","author":"SK Kjaer","year":"2010","unstructured":"Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102(19):1478\u201388.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4540_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/AOG.0000000000000056","volume":"123","author":"LT Thomsen","year":"2014","unstructured":"Thomsen LT, Frederiksen K, Munk C, Junge J, Castle PE, Iftner T, Kjaer SK. High-risk and low-risk human papillomavirus and the absolute risk of cervical intraepithelial neoplasia or cancer. Obstet Gynecol. 2014;123(1):57\u201364.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"4540_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1158\/1055-9965.EPI-07-2691","volume":"17","author":"D Maucort-Boulch","year":"2008","unstructured":"Maucort-Boulch D, Franceschi S, Plummer M. International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers. 2008;17(3):717\u201320.","journal-title":"Cancer Epidemiol Biomarkers"},{"key":"4540_CR50","unstructured":"International Agency for Research on Cancer (IARC) WHOW: GLOBOCAN 2012: Estimated Cervical cancer Incidence, Mortality and Prevalence Worldwide in 2012. In.: IARC & WHO; 2012."},{"issue":"4","key":"4540_CR51","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncology. 2017;3(4):524\u201348.","journal-title":"JAMA oncology"},{"issue":"Suppl 5","key":"4540_CR52","doi-asserted-by":"publisher","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H De Vuyst","year":"2013","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013;31(Suppl 5):F32\u201346.","journal-title":"Vaccine"},{"issue":"4","key":"4540_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/17455057.4.4.357","volume":"4","author":"A Krishnan","year":"2008","unstructured":"Krishnan A, Levine AM. Malignancies in women with HIV infection. Women's Health (Lond Engl). 2008;4(4):357\u201368.","journal-title":"Women's Health (Lond Engl)"},{"key":"4540_CR54","unstructured":"Institut catala d'Oncologgia (ICO): Human Papillomavirus and related diseases report (Swaziland). In. ICO HPV Information Centre; 2015."},{"key":"4540_CR55","volume-title":"Report on cases of cancers in Swaziland- 2014-2015","author":"Swaziland National Cancer Registry","year":"2016","unstructured":"Swaziland National Cancer Registry. Report on cases of cancers in Swaziland- 2014-2015. Mbabane: Ministry of Health; 2016."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4540-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T19:07:00Z","timestamp":1559848020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4540"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4540-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"8 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Swaziland Scientific Ethics Committee (MH599C\/FW00015267\/IRB0009688) and the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (BE 242\/14). Ethics committees approved written informed consent, which was obtained from all the participants prior participating to the study. All sexually active women aged between 15 and 49\u00a0years attending various reproductive health clinics and other units from all the study sites, were eligible for the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"639"}}